Results 161 to 170 of about 25,542 (192)
Some of the next articles are maybe not open access.
The endocannabinoid system in neurodegeneration.
The Italian journal of biochemistry, 2006Endocannabinoids are bioactive lipids, that comprise amides, esters and ethers of long chain polyunsaturated fatty acids. Anandamide (N-arachidonoylethanolamine; AEA) and 2-arachidonoylglycerol (2-AG) are the best studied endocannabinoids, and act as agonists of cannabinoid receptors.
Battista N +3 more
openaire +4 more sources
2017
The endocannabinoid system was only discovered about 25 years ago, but it is now known to be a major modulator of synaptic activity throughout the brain. CB1 receptors are located on presynaptic terminals of neurons that release other neurotransmitters and the action of agonists of these receptors is to turn-off neurotransmitter release.
+4 more sources
The endocannabinoid system was only discovered about 25 years ago, but it is now known to be a major modulator of synaptic activity throughout the brain. CB1 receptors are located on presynaptic terminals of neurons that release other neurotransmitters and the action of agonists of these receptors is to turn-off neurotransmitter release.
+4 more sources
The endocannabinoid signaling system in cancer
Trends in Pharmacological Sciences, 2013Changes in lipid metabolism are intimately related to cancer. Several classes of bioactive lipids play roles in the regulation of signaling pathways involved in neoplastic transformation and tumor growth and progression. The endocannabinoid system, comprising lipid-derived endocannabinoids, their G-protein-coupled receptors (GPCRs), and the enzymes for
PISANTI, SIMONA +4 more
openaire +4 more sources
The Endocannabinoid System and Alzheimer’s Disease
Molecular Neurobiology, 2007The importance of the role of the endocannabinoid system (ECS) in neurodegenerative diseases has grown during the past few years. Mostly because of the high density and wide distribution of cannabinoid receptors of the CB(1) type in the central nervous system (CNS), much research focused on the function(s) that these receptors might play in ...
Cristina, Benito +4 more
openaire +2 more sources
Neurobiology and Systems Physiology of the Endocannabinoid System
Pharmacopsychiatry, 2009Endocannabinoids are synthesised from lipid precursors, are released from postsynaptic neurons in an activity-dependent way, and act as retrograde signalling messengers on specific G (i)-protein-coupled cannabinoid (CB (1)) receptors on presynaptic terminals. Hence, endocannabinoids are in a strategic position to regulate transmitter release.
N, Wegener, M, Koch
openaire +2 more sources
Endocannabinoid System and Cardiometabolic Risk
Clinical Pharmacology & Therapeutics, 2007The increasing prevalence of overweight and obesity counteracts the favorable advances of risk factor management achieved for cardiovascular disease (CVD) prevention. Obese and overweight individuals are at increased risk for CVDs and diabetes mellitus, a risk pattern called "cardiometabolic risk." There is a growing interest concerning the role of the
openaire +2 more sources
The endocannabinoid system in cholestasis
Digestive and Liver Disease, 2011FLOREANI, ANNAROSA +3 more
openaire +2 more sources
Targeting the endocannabinoid system with microbial interventions to improve gut integrity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2021Sahar El Aidy +2 more
exaly
Here, There and Everywhere: the Endocannabinoid System
Journal of Neuroendocrinology, 2008Vettor R. +3 more
openaire +3 more sources